Why Is American Healthcare REIT (AHR) Back On Investors’ Radar?
American Healthcare REIT (AHR) has garnered renewed investor interest following strong Q2 results, increased revenue and net income, and raised full-year earnings guidance for 2026. Despite a recent share price pullback, the stock has delivered significant year-to-date and one-year returns. While some analyses suggest it is undervalued, its high P/E ratio compared to industry averages raises questions about its valuation.
KeyBanc raises American Healthcare REIT price target on pipeline By Investing.com
KeyBanc has increased its price target for American Healthcare REIT (NYSE:AHR) to $68 from $58, maintaining an Overweight rating, citing the company's strong pipeline and projected growth. This revision follows an increase in 2026 and 2027 normalized funds from operations estimates and accounts for approximately $2.4 billion in closed and awarded investments. The REIT is expected to deliver significant FFO growth in 2026 and 2027, supported by favorable supply-demand dynamics and operational execution.
KeyBanc raises American Healthcare REIT price target on pipeline
KeyBanc has increased its price target for American Healthcare REIT (NYSE:AHR) to $68 from $58, maintaining an Overweight rating, citing higher income-producing senior housing growth assumptions and earnings accretion from recent investments. The firm projects significant normalized funds from operations growth for AHR in 2026 and 2027, supported by strong second-quarter 2026 results and an expanding acquisition pipeline. Despite the stock's 36% gain over the past year, it is considered overvalued at current levels.
How Investors May Respond To American Healthcare REIT (AHR) Equity Raise And Higher 2026 Guidance
American Healthcare REIT (AHR) recently completed a US$712.19 million equity offering and simultaneously raised its 2026 earnings guidance due to improved operating performance and lower real estate impairment charges. This capital raise enhances the company's financial flexibility for acquisitions and portfolio optimization, but also introduces dilution risk for investors. The article explores how these developments might impact the company's investment narrative, fair value estimates, and key risks.
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $71
BofA Securities has reiterated its Buy rating for American Healthcare REIT (AHR.US) and set a target price of $71. This indicates a positive outlook from the firm regarding the company's future stock performance.
How Investors May Respond To American Healthcare REIT (AHR) Equity Raise And Higher 2026 Guidance
American Healthcare REIT (AHR) recently completed a US$712.19 million equity offering and simultaneously raised its 2026 earnings guidance, driven by improved operating performance and reduced real estate impairment charges. This capital raise enhances balance sheet flexibility, supporting acquisitions and portfolio optimization, though it introduces dilution risk. While the company projects substantial revenue and earnings growth by 2029, investors should weigh the benefits of financial strength against potential challenges in integrating new assets and the inherent dilution from the share offering.
BofA Securities Adjusts American Healthcare REIT Price Target to $71 From $67
BofA Securities has raised its price target for American Healthcare REIT to $71 from $67. This adjustment follows other recent analyst updates, including RBC and Truist Securities, who also increased their price targets for the company. The REIT, which specializes in healthcare real estate, recently announced its Q2 2026 earnings, reporting increased normalized FFO and revenue, and revised its full-year guidance upwards.
American Healthcare REIT (NYSE:AHR) Price Target Raised to $61.00 at Royal Bank Of Canada
Royal Bank of Canada has raised its price target for American Healthcare REIT (NYSE:AHR) to $61.00 from $56.00, maintaining an "outperform" rating, which suggests a 13.2% upside. This follows the company's strong quarterly performance, where it surpassed EPS and revenue expectations. Analysts generally hold a "Moderate Buy" consensus rating with an average target price of $60.08.
E. Ohman J or Asset Management AB Invests $2.91 Million in American Healthcare REIT, Inc. $AHR
E. Ohman J or Asset Management AB recently acquired a new stake of 55,726 shares in American Healthcare REIT, Inc. (NYSE:AHR) worth approximately $2.91 million. This investment comes as American Healthcare REIT exceeded quarterly earnings expectations with $0.16 EPS and $674.25 million in revenue, leading analysts to maintain a "Moderate Buy" rating with an average price target of $58.83. The company also declared a quarterly dividend of $0.25 per share.
American Healthcare REIT (AHR) Following Its Equity Raise Has Valuation Back In Focus
American Healthcare REIT (AHR) recently completed a $712.2 million equity offering to fund senior housing acquisitions, bringing its valuation into focus. The stock has shown strong performance, with a 40.34% total shareholder return over one year. While one narrative suggests a 7.7% undervaluation with a fair value of $60.07 per share due to strong demographic trends and low supply in senior housing, another view highlights potential valuation risk with a P/E ratio of 99.9x against a fair ratio of 50.8x.
American Healthcare REIT Drops 5.2% Amid Sector-Wide Selling
American Healthcare REIT (AHR) experienced a 5.2% decline on Tuesday, closing at $52.59, as a broader sell-off impacted the entire healthcare real estate sector. This synchronized drop, also affecting peers like Ventas (VTR), CareTrust REIT (CTRE), and Jamestown (JAN), suggests a shift in investor sentiment possibly due to interest rate expectations or economic concerns rather than company-specific issues. The significant trading volume indicates institutional repositioning, raising questions about ongoing sector-wide headwinds.
American Healthcare REIT (AHR) Falls as New Equity Offering Appears to Outweigh Strong Q2 Results
American Healthcare REIT (AHR) experienced a 4.8% drop in its stock price despite reporting strong Q2 results, including an earnings and revenue beat and raised full-year guidance. The decline is attributed to a new common stock offering, which typically causes dilution concerns among investors. This offering, along with significant equity financing activity, appears to have overshadowed the positive financial performance.
American Healthcare REIT (AHR) Falls as New Equity Offering Appears to Outweigh Strong Q2 Results
American Healthcare REIT (AHR) experienced a 4.8% drop in its stock price despite reporting strong second-quarter results, including an earnings and revenue beat and raised full-year guidance. The decline is attributed to a new common stock offering, which likely created investor concerns about dilution, overshadowing the positive financial performance. Insider selling and shifts in institutional holdings also highlight market activity around AHR.
Why is American Healthcare REIT stock sliding today?
American Healthcare REIT (AHR) stock is falling 4.5% in pre-open trading due to a substantial equity offering that triggered a dilution-driven sell-off. The company priced an underwritten public offering of 13,250,000 shares, aiming to raise approximately $712.2 million for a senior housing properties portfolio acquisition and other investments. Despite the short-term dilution, underlying fundamentals are solid, and the market's reaction is specific to the share count increase rather than broader economic factors.
American Healthcare REIT Announces Pricing of Public Offering of Common Stock
American Healthcare REIT (NYSE: AHR) has announced the pricing of a public offering of 13,250,000 shares of its common stock, expecting to raise approximately $712.2 million in gross proceeds. The offering is connected to forward sale agreements with Morgan Stanley, Citigroup, and KeyBanc Capital Markets, with the proceeds intended for a pending acquisition of senior housing properties, future investments, and general corporate purposes. The underwriters also have a 30-day option to purchase an additional 1,987,500 shares.
American Healthcare REIT prices $712M stock offering
American Healthcare REIT, Inc. (NYSE:AHR) has priced an underwritten public offering of 13,250,000 shares of common stock through forward sale agreements, aiming for approximately $712.2 million in gross proceeds. The company plans to use the net proceeds from the eventual settlement of these agreements, anticipated within 24 months, for a pending acquisition of senior housing properties, future investments, and general corporate purposes. Morgan Stanley, Citigroup, and KeyBanc Capital Markets are acting as joint book-running managers for the offering.
Citizens reiterates American Healthcare REIT stock rating on strong results
Citizens reiterated a Market Outperform rating and $65.00 price target for American Healthcare REIT (NYSE:AHR) after the company reported strong second-quarter 2026 results, exceeding analyst and consensus estimates. The outperformance was driven by effective operating expense management and lower interest expenses, leading management to raise full-year normalized FFO guidance. The company also demonstrated significant investment activity, accelerating its external growth strategy.
American Healthcare REIT (NYSE: AHR) lines up $873M Kensington senior housing acquisition
American Healthcare REIT (AHR) plans to acquire the Kensington Portfolio, comprising eight senior housing communities with 745 units across four states, for $873 million. The transaction is structured with multiple purchase agreements and financing through equity offerings, credit agreement borrowings, debt assumption, and cash. Key conditions include lender consent and stabilization of net operating income for certain properties, with initial closing targeted for September 1, 2026.
US REIT Stocks Back In Focus As Lower Yields Lift Healthcare Property Names
Softer US jobs data and easing Treasury yields are bringing attention back to interest rate-sensitive US REIT stocks. This article highlights three healthcare REITs – American Healthcare REIT (AHR), National Healthcare Properties (NHP), and CareTrust REIT (CTRE) – that appear well-positioned for the current macro environment. It discusses their focus on senior housing and skilled nursing, along with their growth strategies, while also noting potential risks like debt-funded expansion and new management.
Citizens reiterates American Healthcare REIT stock rating on strong results
Citizens has reiterated its Market Outperform rating and $65.00 price target for American Healthcare REIT (NYSE:AHR) after the company surpassed Q2 2026 earnings estimates. The outperformance led management to raise its full-year 2026 normalized FFO guidance, signaling strong operating momentum and an accelerated external growth strategy, despite the stock trading near its 52-week high and appearing overvalued according to InvestingPro.
American Healthcare REIT, CareTrust, National HealthCare Corp., Strawberry Fields deliver second-quarter earnings reports
American Healthcare REIT, CareTrust REIT, National HealthCare Corp., and Strawberry Fields reported their second-quarter earnings. American Healthcare REIT saw double-digit same-store net operating growth, while CareTrust REIT recorded its largest single investment quarter in history, driven by skilled nursing expansion. National HealthCare Corp.'s net operating revenues increased by 8.8% year-over-year, largely due to skilled nursing facility acquisitions, and Strawberry Fields REIT collected 100% of contractual rents and secured a new credit facility for acquisition growth.
Pacer Advisors Inc. Buys New Shares in American Healthcare REIT, Inc. $AHR
Pacer Advisors Inc. has acquired a new stake of 29,205 shares in American Healthcare REIT (NYSE:AHR), valued at approximately $1.38 million. American Healthcare REIT reported strong Q1 earnings, exceeding analyst estimates with an EPS of $0.16 and revenue of $674.25 million, a 24.3% year-over-year increase. Despite a "Moderate Buy" consensus from analysts, concerns remain regarding the stock's valuation, insider selling, and a dividend payout ratio exceeding 100%.
How Investors May Respond To American Healthcare REIT (AHR) Raising 2026 Earnings Guidance After Lower Impairments
American Healthcare REIT (AHR) reported improved Q2 2026 results, including higher sales, revenue, and net income, alongside significantly lower real estate impairment charges. The company also raised its full-year 2026 net income and diluted EPS guidance. This upgrade reinforces the investment narrative of sustained demand in senior housing, though investors are cautioned about potential cooling as occupancy normalizes.
San Jose Area Senior Multifamily Community Sells for $103M
American Healthcare REIT has acquired Avella at Almaden, a 200-unit luxury senior community in San Jose, Calif., for $102.8 million. The property, originally developed by The 11th Group Inc., Affinius Capital, and Alliance Residential, offers assisted living and memory care units with various amenities. It was brought online in 2020 and had a $59.2 million refinancing loan originated in 2023 by Walton Street Capital.
American Healthcare REIT (NYSE:AHR) Releases Earnings Results, Beats Estimates By $0.40 EPS
American Healthcare REIT (NYSE:AHR) reported strong Q1 earnings, beating analyst EPS estimates by $0.40 with $0.54 per share. While revenue grew 24.3% year-over-year to $445.63 million, it missed forecasts. The company updated its fiscal 2026 EPS guidance to $2.15–$2.19, and despite a slight dip in share price post-results, analysts maintain a "Moderate Buy" rating with a $58.83 average price target.
American Healthcare REIT Announces Second Quarter 2026 Results; Increases Full Year 2026 Guidance
American Healthcare REIT (AHR) announced strong second-quarter 2026 results, reporting GAAP net income of $30.6 million and Normalized Funds From Operations (NFFO) of $0.54 per diluted share. The company increased its full-year 2026 guidance for total portfolio Same-Store Net Operating Income (NOI) growth to 11.0%-13.0% and NFFO per diluted share to $2.15-$2.19, driven by significant new investments of $1.4 billion year-to-date and robust operating performance in its senior housing segments. AHR also strengthened its balance sheet through equity offerings and an expanded credit facility, improving its Net Debt-to-Annualized Adjusted EBITDA to 2.5x.
American Healthcare REIT, Inc. $AHR Shares Purchased by Bank of America Corp DE
Bank of America Corp DE increased its stake in American Healthcare REIT (AHR) by 28.1% in Q1, now owning 3.24 million shares valued at $152.6 million. Despite missing earnings estimates with $0.13 EPS, AHR reported a 20.4% year-over-year revenue growth. Analysts have a "Moderate Buy" consensus with an average price target of $58.83, and the company pays a quarterly dividend of $0.25 per share.
American Healthcare REIT Inc (AHR) Q2 2026: Everything You Need To Know Ahead Of Earnings
American Healthcare REIT Inc (AHR) is scheduled to release its Q2 2026 earnings on August 6, 2026, with revenue expected to be $663.16 million and earnings at $0.16 per share. Full-year 2026 revenue and earnings estimates are $2705.02 million and $0.64 per share, respectively, showing recent adjustments in analyst expectations. Analysts have an average price target of $60.40 for AHR, implying a 10.89% upside from its current price, with an "Outperform" recommendation.
The Manufacturers Life Insurance Company Has $8.52 Million Stock Holdings in American Healthcare REIT, Inc. $AHR
The Manufacturers Life Insurance Company significantly increased its stake in American Healthcare REIT (AHR) by 119.8% in the first quarter, now holding 180,573 shares valued at approximately $8.52 million. This move contributes to institutional investors collectively owning 16.68% of AHR. Despite the company missing its Q1 EPS consensus estimate, analysts maintain a "Moderate Buy" rating for American Healthcare REIT, with an average price target of $58.83, while some insiders have recently sold shares.
EX-99.1
American Healthcare REIT, Inc. (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for the first quarter ending March 31, 2026. This cash distribution will be paid around April 17, 2026, to shareholders of record as of March 31, 2026. The company specializes in acquiring, owning, and operating a diverse portfolio of clinical healthcare real estate.
American Healthcare REIT Inc expected to post earnings of 17 cents a share - Earnings Preview
American Healthcare REIT Inc is projected to report earnings of 17 cents per share, according to this earnings preview. The article indicates that full details are available to subscribers of TradingView, which aggregates content from Reuters and other news sources.
California State Teachers Retirement System Purchases 40,671 Shares of American Healthcare REIT, Inc. $AHR
The California State Teachers Retirement System increased its stake in American Healthcare REIT, Inc. (AHR) by 25.4%, acquiring an additional 40,671 shares to bring its total holding to 200,865 shares valued at approximately $9.5 million. Despite missing earnings and revenue estimates in its latest quarterly report, the company reported 20.4% year-over-year revenue growth and declared a $0.25 per share quarterly dividend. Analysts maintain a "Moderate Buy" consensus with a target price of $58.83, while institutional ownership remains significant at 16.68%.
PVG Asset Management Corp Makes New $894,000 Investment in American Healthcare REIT, Inc. $AHR
PVG Asset Management Corp initiated a new position in American Healthcare REIT (AHR) during the first quarter, purchasing 19,237 shares valued at $894,000. Other hedge funds have also adjusted their holdings in AHR, with institutional investors and hedge funds collectively owning 16.68% of the company. AHR reported quarterly revenue of $650.77 million and an EPS of $0.13, missing analyst estimates, but analysts maintain a "Moderate Buy" consensus with an average price target of $58.83 and a quarterly dividend of $0.25.
American Healthcare REIT, Inc. Revenue Breakdown – NYSE:AHR
American Healthcare REIT, Inc. (NYSE:AHR) generated $2.26 billion USD in revenue last year. The largest portion, $1.76 billion USD, came from its Integrated Senior Health Campuses segment. The United States was the primary geographic contributor, accounting for $2.25 billion USD of the total revenue.
American Healthcare REIT buys San Jose senior living center for nearly $103M
American Healthcare REIT has acquired a 200-unit senior living community in San Jose, California, for $102.75 million. The property, located at 4610 Almaden Expressway, offers assisted living and memory care services. This acquisition highlights continued investment in senior living facilities in the region.
American Healthcare REIT (AHR) to Post Quarterly Earnings on Thursday
American Healthcare REIT (AHR) is scheduled to release its Q2 2026 earnings after market close on Thursday, August 6th, with analysts projecting earnings of $0.1372 per share and revenue of $669.1 million. This follows a Q1 2026 earnings report that missed analyst expectations for EPS and revenue. The company also recently declared a quarterly dividend of $0.25, and analysts maintain a "Moderate Buy" rating with a consensus price target of $58.83.
Cetera Investment Advisers Purchases 20,075 Shares of American Healthcare REIT, Inc. $AHR
Cetera Investment Advisers has increased its stake in American Healthcare REIT (AHR) by 8.1%, now holding 268,749 shares valued at approximately $12.7 million. Other institutional investors have also adjusted their positions in AHR, which currently has 16.68% institutional ownership. Despite missing analyst EPS estimates, the company reported a 20.4% year-over-year revenue increase and maintains a positive analyst consensus with a "Moderate Buy" rating.
First Trust Advisors LP Grows Stock Holdings in American Healthcare REIT, Inc. $AHR
First Trust Advisors LP increased its stake in American Healthcare REIT, Inc. (AHR) by 27.5% in the first quarter, now holding 448,094 shares valued at $21.1 million. Despite a reported revenue increase of 20.4%, the company missed earnings expectations but issued positive full-year 2026 EPS guidance. Analysts maintain a "Moderate Buy" consensus with an average price target of $58.83, while insiders have recently sold shares worth approximately $1.49 million.
American Healthcare REIT Number of Employees 2026 | Employee Count & Headcount Data
American Healthcare REIT (AHR) has approximately 817 employees worldwide as of March 2026, representing a 0.8% growth since 2023 but a 0.8% year-over-year decline in 2026. The company is actively hiring, with 2,017 active job postings in 2026, though this is a 29.0% decline from 2025. The majority of its workforce is in the United States, and the average salary is $64,938.
American Healthcare REIT, Inc. Revenue Breakdown – BMV:AHR
American Healthcare REIT, Inc. (BMV:AHR) generated 40.74 billion MXN in revenue last year, with its Integrated Senior Health Campuses segment being the top performer contributing 31.80 billion MXN. The United States was the greatest regional contributor, accounting for 40.63 billion MXN. These figures show a slight decrease in the top-performing segment and overall regional contribution compared to the previous year.
American Healthcare REIT (NYSE:AHR) Sets New 52-Week High on Analyst Upgrade
American Healthcare REIT (NYSE:AHR) reached a new 52-week high after Citizens JMP raised its price target and maintained an "outperform" rating. The stock has a consensus "Moderate Buy" rating from analysts with an average price target of $58.83. Despite missing recent EPS and revenue estimates, the company reported strong quarterly revenue growth and paid a dividend.
Citizens JMP Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $65
Citizens JMP has reiterated its Buy rating on American Healthcare REIT (AHR.US) and increased its target price to $65. This indicates a positive outlook from the analyst firm regarding the company's stock performance.
BlackRock (AHR holder) reports 22.19M-share, 11.5% stake in American Healthcare REIT
BlackRock, Inc. has filed a Schedule 13G/A, disclosing a beneficial ownership of 22,190,732 shares of American Healthcare REIT Inc (AHR) common stock, which represents an 11.5% stake as of June 30, 2026. The filing indicates BlackRock has sole voting power over 21,590,010 shares and sole dispositive power over all 22,190,732 shares. No single client of BlackRock holds more than five percent of AHR's outstanding common shares.
AHR Maintained by Citizens -- Price Target Raised to $65.00
Citizens has maintained a "Market Outperform" rating for American Healthcare REIT Inc (AHR) and increased its price target from $60.00 to $65.00. Despite this positive analyst outlook, the stock has a high P/E ratio of 99.03 and a low GF Score™ of 32/100, indicating potential overvaluation and areas for financial improvement. Insider selling of $1.5 million in the last three months also suggests a cautious sentiment.
Citizens raises American Healthcare REIT price target on growth outlook
Citizens has increased its price target for American Healthcare REIT (NYSE:AHR) to $65 from $60, maintaining a Market Outperform rating. The firm anticipates continued FFO growth above the industry average, supported by strong revenue growth and accretive equity-funded acquisitions. This positive outlook is echoed by other analysts, with Barclays initiating coverage with an overweight rating and KeyBanc also raising its price target, highlighting the company's robust growth trajectory.
American Healthcare REIT, Inc. (NYSE:AHR) Receives Consensus Rating of "Moderate Buy" from Analysts
American Healthcare REIT, Inc. (NYSE:AHR) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $58.42, slightly above its current trading price of $57.37. The company recently reported quarterly EPS of $0.13, missing estimates, while revenue increased by 20.4% year-over-year. Management provided a fiscal 2026 EPS guidance of $2.03–$2.09, and the company paid a quarterly dividend of $0.25 per share.
Swiss National Bank Has $16.55 Million Stake in American Healthcare REIT, Inc. $AHR
The Swiss National Bank increased its stake in American Healthcare REIT (AHR) by 5.6% in Q1, now holding 351,000 shares valued at $16.55 million. AHR's stock saw a 1.8% rise, though its Q1 EPS of $0.13 missed estimates, despite a 20.4% year-over-year revenue growth. The company has a "Moderate Buy" consensus rating from analysts, with a target price of $58.42, and recently paid a quarterly dividend of $0.25 per share.
American Healthcare REIT (AHR) Could Be 6% Undervalued After Leadership Changes
American Healthcare REIT (AHR) recently underwent a leadership change, with co-founder Jeffrey Hanson taking over as CEO and Chairman, following which the stock has seen significant price appreciation. The article explores two contrasting views on AHR's valuation: one suggesting it's 6.1% undervalued based on a fair value estimate of $60.07, and another arguing it appears expensive based on its high P/E ratio compared to industry averages, signaling that much optimism is already priced in. Investors are encouraged to review both the positive and cautionary signs before making investment decisions.
American Healthcare REIT Makes Four Leadership Appointments
American Healthcare REIT (NYSE: AHR) has announced four new leadership appointments. Jeff Hanson has been named CEO, succeeding Danny Prosky, who is retiring but will remain on the board. Gabe Willhite has been appointed president, and Scott Estes has been named lead independent director.
American Healthcare REIT Announces Strategic Leadership Realignment
American Healthcare REIT (AHR) has announced a leadership realignment to support its growth strategy. Co-founder Jeff Hanson is now permanent CEO, Gabe Willhite has been promoted to President and COO, and founding CEO Danny Prosky retired but remains on the board. These changes aim to capitalize on investment opportunities in senior housing and strengthen corporate governance.
